Titles
- Best practices in developing proprietary names for human prescription drug products1
- Best practices in specialty provider recruitment and retention: challenges and solutions1
- Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report1
- Better access to palliative care can improve the experience for metastatic breast cancer patients1
- Better and faster: how safety-net providers are redesigning care1
- Better health, greater social cohesion linked to voter participation1
- Beyond age rating: spreading risk in health insurance markets1
- Beyond health care: the role of social determinants in promoting health and health equity1
- Beyond referral: pediatric care linkages to improve developmental health1
- Beyond the bundle: reducing the risk of central line-associated bloodstream infections1
- Beyond the case count: the wide-ranging disparities of COVID-19 in the United States1
- Beyond the count: preventing retention of foreign objects1
- Billions in estimated Medicare Advantage payments from chart reviews raise concerns1
- Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns1
- Bioanalytical method validation1
- Bioavailability studies submitted in NDAs or INDs: general considerations1
- Bioburden on surgical instruments1
- Biocompatibility testing of medical devices: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters1
- Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report1